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Human T cell leukemia virus type 1 (HTLV-1) has been
identified as the etiologic agent of adult T cell leukemia
(ATL) and HTLV-1-associated myelopathy/tropical spastic
paraparesis (HAM/TSP). Numerous studies have demon-
strated that patients diagnosed with HAM/TSP exhibit
rapid activation and maturation of dendritic cells (DCs)
while ATL is associated with their maturation defect. In
addition to T cells, HTLV-1 is known to infect DCs. HTLV-
1 infection of DCs could alter general DC function or the
specific processing and/or presentation of HTLV-1-spe-
cific peptides, potentially playing a major role in the
course of HTLV-1-associated disease. In this regard, we
have demonstrated that an important antigen receptor on
DCs, DC-SIGN serves as a receptor for HTLV-1 binding
using a quantum dot-based fluorescent binding assay. We
have also demonstrated that gene silencing of DC-SIGN
inhibits the infection of DC in a DC/T cell co-infection
system. Furthermore, expression of DC-SIGN in B cells
enhances viral binding, integration, and infection. These
investigations, which consider the involvement of DC sur-
face molecules in HTLV-1 pathogenesis, are the first explo-
rations of the intricate mechanisms that underlie the
interactions between DCs and HTLV-1.
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